Claude Lilly - Erie Indemnity Independent Director
| ERIE Stock | USD 381.56 1.10 0.29% |
Director
Dr. Claude C. Lilly, III., Ph.D. is no longer Independent Director of the Company effective April 30, 2019. He is Retired President, Presbyterian College, Clinton, SC, 20122015 Dean, College of Business and Behavioral Science, Clemson University, 20072012 Director, Charlotte Branch of the Federal Reserve Bank of Richmond, 20072012. Dr. Lilly has extensive experience with risk assessment and management, and broad knowledge of insurance operations, regulation of insurance companies and financial reporting. He has prior experience as an Assistant Deputy Insurance Commissioner for the State of Georgia. He served as an advisor to the Florida Insurance Department and the Florida House of Representatives when it rewrote the states insurance code, and as director of insurance research centers at Florida State University and the University of Southern California since 2000.
| Age | 70 |
| Tenure | 24 years |
| Address | 100 Erie Insurance Place, Erie, PA, United States, 16530-0001 |
| Phone | 814 870 2000 |
| Web | https://www.erieinsurance.com |
Erie Indemnity Management Efficiency
The company has return on total asset (ROA) of 0.1467 % which means that it generated a profit of $0.1467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2867 %, meaning that it created $0.2867 on every $100 dollars invested by stockholders. Erie Indemnity's management efficiency ratios could be used to measure how well Erie Indemnity manages its routine affairs as well as how well it operates its assets and liabilities. At present, Erie Indemnity's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, Erie Indemnity's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Net Tangible Assets is expected to grow to about 1.5 B, whereas Other Assets are forecasted to decline to about 36.7 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Morton Schapiro | Marsh McLennan Companies | 67 | |
| Ralph Nicoletti | Arthur J Gallagher | 63 | |
| Michael Goldberg | eHealth | 60 | |
| Julie Rice | Willis Towers Watson | N/A | |
| Christopher Sobecki | Willis Towers Watson | 59 | |
| Deborah Hopkins | Marsh McLennan Companies | 66 | |
| David Coldman | Arthur J Gallagher | 73 | |
| Mahendra Gupta | Brp Group | 61 | |
| Maria Marques | Marsh McLennan Companies | 58 | |
| Steven Markscheid | Fanhua Inc | 62 | |
| Christopher Miskel | Arthur J Gallagher | 46 | |
| Jack Oliver | eHealth | 49 | |
| Philippe Amouyal | Willis Towers Watson | 58 | |
| Kay McCurdy | Arthur J Gallagher | 70 | |
| Teresa Clarke | Arthur J Gallagher | 58 | |
| W Capps | Brp Group | 66 | |
| Ellen Tauscher | eHealth | 66 | |
| Denis Kelly | Willis Towers Watson | 68 | |
| Steven Mills | Marsh McLennan Companies | 69 | |
| Oscar Martin | Marsh McLennan Companies | 71 | |
| Yunxiang Tang | Fanhua Inc | 67 | |
Management Performance
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.15 |
Erie Indemnity Leadership Team
Elected by the shareholders, the Erie Indemnity's board of directors comprises two types of representatives: Erie Indemnity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Erie. The board's role is to monitor Erie Indemnity's management team and ensure that shareholders' interests are well served. Erie Indemnity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Erie Indemnity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Claude Lilly, Independent Director | ||
| CPCU CPA, Ex CFO | ||
| Robert Ingram, Executive Vice President CIO | ||
| John Kearns, Executive VP of Sales and Marketing | ||
| George Lucore, Independent Director | ||
| Ronald Habursky, Senior Officer | ||
| Bill Matrogran, Vice Operations | ||
| Scott Beilharz, Vice President | ||
| Elizabeth Vorsheck, Independent Director | ||
| Jonathan Hagen, Independent Director | ||
| Dionne Oakley, Executive Vice President - Human Resources & Strategy | ||
| Martin Sheffield, Independent Director | ||
| Scott Hartz, Independent Director | ||
| Patrick Burns, Interim Executive Vice President - Services | ||
| Keith Kennedy, Senior Innovation | ||
| Julie CPA, Executive CFO | ||
| Brian Esq, Corporate VP | ||
| Lorianne Feltz, Executive Vice President - Services | ||
| Richard Stover, Independent Director | ||
| Richard Burt, Executive VP of Products | ||
| CPA CIC, President CEO | ||
| CIPM CIPP, Senior Resources | ||
| Eugene Connell, Independent Director | ||
| Marc CIC, Senior Underwriting | ||
| Gregory Gutting, Interim CFO, Interim Executive VP and Controller | ||
| Brian Hudson, Independent Director | ||
| Charles CIC, Senior Marketing | ||
| Terrence Cavanaugh, CEO and President Director, Member of Investment Committee, Member of Charitable Giving Committee and Member of Strategy Committee | ||
| LuAnn Datesh, Independent Director | ||
| Douglas Smith, Executive Vice President - Products and of Sales and Marketing | ||
| Jeffrey CPCU, Senior Services | ||
| CPCU FCAS, Ex Products | ||
| Charles Fletcher, Senior Marketing | ||
| Parthasarathy Srinivasa, Executive Officer | ||
| CPCU CIC, Senior Service | ||
| Ralph Borneman, Director | ||
| Robert Wilburn, Independent Director | ||
| Thomas Hagen, Independent Chairman of the Board | ||
| George Dufala, Executive VP of Services | ||
| Karen Skarupski, Senior Resources | ||
| Thomas Palmer, Independent Director | ||
| Sean McLaughlin, Executive Vice President General Counsel, Secretary | ||
| Timothy NeCastro, President CEO - Designate | ||
| Lorianne CPCU, Executive Service |
Erie Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Erie Indemnity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.14 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 19.67 B | ||||
| Shares Outstanding | 46.19 M | ||||
| Shares Owned By Insiders | 45.51 % | ||||
| Shares Owned By Institutions | 36.86 % | ||||
| Number Of Shares Shorted | 775.7 K | ||||
| Price To Earning | 46.37 X |
Pair Trading with Erie Indemnity
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Erie Indemnity position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erie Indemnity will appreciate offsetting losses from the drop in the long position's value.Moving together with Erie Stock
| 0.77 | AJG | Arthur J Gallagher Earnings Call This Week | PairCorr |
| 0.77 | AON | Aon PLC Earnings Call This Week | PairCorr |
Moving against Erie Stock
| 0.74 | FANH | Fanhua Inc | PairCorr |
| 0.49 | RELI | Reliance Global Group | PairCorr |
| 0.43 | EHTH | eHealth Financial Report 14th of May 2024 | PairCorr |
| 0.41 | GOCO | GoHealth Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Erie Indemnity could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Erie Indemnity when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Erie Indemnity - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Erie Indemnity to buy it.
The correlation of Erie Indemnity is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Erie Indemnity moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Erie Indemnity moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Erie Indemnity can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Erie Indemnity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade Erie Stock refer to our How to Trade Erie Stock guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Erie Stock analysis
When running Erie Indemnity's price analysis, check to measure Erie Indemnity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Erie Indemnity is operating at the current time. Most of Erie Indemnity's value examination focuses on studying past and present price action to predict the probability of Erie Indemnity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Erie Indemnity's price. Additionally, you may evaluate how the addition of Erie Indemnity to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |
Is Erie Indemnity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Erie Indemnity. If investors know Erie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Erie Indemnity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.697 | Dividend Share 4.845 | Earnings Share 8.52 | Revenue Per Share 70.773 | Quarterly Revenue Growth 0.167 |
The market value of Erie Indemnity is measured differently than its book value, which is the value of Erie that is recorded on the company's balance sheet. Investors also form their own opinion of Erie Indemnity's value that differs from its market value or its book value, called intrinsic value, which is Erie Indemnity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Erie Indemnity's market value can be influenced by many factors that don't directly affect Erie Indemnity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Erie Indemnity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Erie Indemnity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Erie Indemnity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.